US Patent Issued to GLAXOSMITHLINE INTELLECTUAL PROPERTY (NO. 2) on Oct. 28 for "Biopharmaceutical compositions" (Massachusetts, Pennsylvania Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,454,571, issued on Oct. 28, was assigned to GLAXOSMITHLINE INTELLECTUAL PROPERTY (NO. 2) Ltd. (Brentford, Great Britain).

"Biopharmaceutical compositions" was invented by Myrna A. Monck (Waltham, Mass.), Narendra B. Bam (King of Prussia, Pa.), Jennifer Dally (King of Prussia, Pa.) and Michelle Spatara (King of Prussia, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to compositions for treating interleukin 5 (IL-5) mediated diseases, and related methods."

The patent was filed on Aug. 5, 2022, under Application No. 17/881,988.

*For further information, including images, charts and tables, please visit: http://patft.usp...